@article{3086203,
    title = "Intratumor and circulating clonal heterogeneity shape the basis of precision breast cancer therapy",
    author = "Ziogas, D.E. and Spiliotis, J. and Lykoudis, E.G. and Zografos, G.C. and Roukos, D.H.",
    journal = "Future Oncology",
    year = "2017",
    volume = "13",
    number = "2",
    pages = "113-116",
    publisher = "Future Medicine Ltd",
    issn = "1479-6694, 1744-8301",
    doi = "10.2217/fon-2016-0307",
    keywords = "complementary DNA;  trastuzumab;  trastuzumab emtansine, breast cancer;  cancer therapy;  gene mutation;  gene sequence;  genetic heterogeneity;  genetic variability;  human;  metastasis;  next generation sequencing;  overall survival;  priority journal;  Review;  translational research;  Breast Neoplasms;  disease course;  female;  genetic heterogeneity;  genetics;  genomics;  high throughput sequencing;  metabolism;  multimodality cancer therapy;  pathology;  personalized medicine;  procedures;  tumor embolism, Breast Neoplasms;  Combined Modality Therapy;  Disease Progression;  Female;  Genetic Heterogeneity;  Genomics;  High-Throughput Nucleotide Sequencing;  Humans;  Neoplastic Cells, Circulating;  Precision Medicine"
}